Dow Down 0.92% Nasdaq Down 0.83%

Geron Corporation (GERN)

-NasdaqGS
2.15 0.01(0.46%) Oct 22, 4:00PM EDT
Prev Close:2.16
Open:2.19
Bid:1.83 x 400
Ask:2.28 x 100
1y Target Est:4.13
Beta:2.3
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.14 - 2.20
52wk Range:1.31 - 7.36
Volume:1,053,006
Avg Vol (3m):2,044,440
Market Cap:337.30M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 0.46%337.30M
BMY85.95B
GSK106.67B
NVS213.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):277.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-1.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback